X-Chem will screen its DNA-encoded libraries to discover novel antivirals for Gilead.
Enyo Pharma has successfully identified potential targets of its preclinical molecule series EYP002 with Charles River's technology.
The careful optimization of tumor-bearing humanized models leads to highly useful preclinical immuno-oncology platforms for accelerated immunotherapy…
HitGen has formed a drug discovery research collaboration with Boehringer Ingelheim to identify novel small-molecule leads.
Bay Area drug discovery company Verge Genomics has formed industry and academic alliances in neuro disorders.
Aquila BioMedical signed an extended contract with Macrophage Pharma to support its preclinical immuno-oncology programs.
Science Exchange is providing its R&D service marketplace to QB3, the University of California incubator for life sciences startups.
Janssen has developed a mobile toolkit for trial supply management and patient engagement that can track adherence to each pill.
Biopharma executives share how they manage outsourcing relationships at this year's Drug Development Forum.
Treos Bio has tapped PPD to manage its first-in-human study on its lead cancer vaccine for colorectal cancer.
The deal gives Boehringer access to Gubra’s expertise in the design, synthesis and preclinical testing of therapeutic peptides.